Update shared on06 Oct 2025
Fair value Increased 2.17%Analysts have raised their price target for IHH Healthcare Berhad from RM8.24 to RM8.42, with modest improvements in revenue growth forecasts cited as the primary driver for the adjustment.
What's in the News
- IHH Healthcare Berhad has announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).
- The dividend's ex-date is set for 29 September 2025 (Key Developments).
- Entitlement date for the dividend is 30 September 2025 (Key Developments).
- The payment date for the announced dividend is 30 October 2025 (Key Developments).
Valuation Changes
- Fair Value Estimate has increased modestly from MYR 8.24 to MYR 8.42.
- Discount Rate remains unchanged at 8.45%.
- Revenue Growth Forecast has risen slightly, moving from 9.12% to 9.15%.
- Net Profit Margin Estimate has decreased marginally, from 8.47% to 8.29%.
- Future P/E Ratio is now higher, rising from 34.19x to 35.63x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.